Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001104659-21-053339

Options or other derivatives

  • Chief Financial Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Roche Corleen M. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-04-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +125,000 $27.53 2031-04-19 125,000 125,000 D
Loading xslF345X03/tm2113705-2_4seq1.xml…